Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes

Por Kramer, Caroline K., Leitão, Cristiane B., Canani, Luís H., Gross, Jorge L.
Publicado em 2008

A Prospective Study of Abdominal Obesity and Coronary Artery Calcium Progression in Older Adults

Por Kramer, Caroline K., von Mühlen, Denise, Gross, Jorge L., Barrett-Connor, Elizabeth
Publicado em 2009

Screening for coronary artery disease in patients with type 2 diabetes: a meta-analysis and trial sequential analysis

Por Rados, Dimitris V, Pinto, Lana C, Leitão, Cristiane B, Gross, Jorge L
Publicado no BMJ Open (2017)

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis

Por Pinto, Lana C., Rados, Dimitris V., Barkan, Sabrina S., Leitão, Cristiane B., Gross, Jorge L.
Publicado no Sci Rep (2018)

Blood Pressure and Fasting Plasma Glucose Rather Than Metabolic Syndrome Predict Coronary Artery Calcium Progression: The Rancho Bernardo Study

Por Kramer, Caroline K., von Mühlen, Denise, Gross, Jorge L., Laughlin, Gail A., Barrett-Connor, Elizabeth
Publicado em 2009

Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies

Por Kramer, Caroline K., Rodrigues, Ticiana C., Canani, Luis H., Gross, Jorge L., Azevedo, Mirela J.
Publicado em 2011

Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis

Por Pinto, Lana C., Falcetta, Mariana R., Rados, Dimitris V., Leitão, Cristiane B., Gross, Jorge L.
Publicado no Sci Rep (2019)

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado em 2013

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Por Bailey, Clifford J, Gross, Jorge L, Hennicken, Delphine, Iqbal, Nayyar, Mansfield, Traci A, List, James F
Publicado em 2013

Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes

Por Wolffenbuttel, Bruce H.R., Herman, William H., Gross, Jorge L., Dharmalingam, Mala, Jiang, Honghua H., Hardin, Dana S.
Publicado em 2013

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

Por Pan, Changyu, Gross, Jorge L., Yang, Wenying, Lv, Xiaofeng, Sun, Li, Hansen, Charlotte Thim, Xu, Hongfei, Wagner, Robert
Publicado no Drugs R D (2016)

Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial

Por Paula, Tatiana P., Viana, Luciana V., Neto, Alessandra T. Z., Leitão, Cristiane B., Gross, Jorge L., Azevedo, Mirela J.
Publicado no J Clin Hypertens (Greenwich) (2015)

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Por Schernthaner, Guntram, Gross, Jorge L., Rosenstock, Julio, Guarisco, Michael, Fu, Min, Yee, Jacqueline, Kawaguchi, Masato, Canovatchel, William, Meininger, Gary
Publicado em 2013

Endothelin-1 gene polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus

Por Zanatta, Claudete M., Crispim, Daisy, Sortica, Denise A., Klassmann, Lucas P., Gross, Jorge L., Gerchman, Fernando, Canani, Luís H.
Publicado no Diabetol Metab Syndr (2015)

Fiber intake and inflammation in type 1 diabetes

Por Bernaud, Fernanda S R, Beretta, Mileni Vanti, do Nascimento, Cigléa, Escobar, Fabrícia, Gross, Jorge L, Azevedo, Mirela J, Rodrigues, Ticiana C
Publicado em 2014

Hypertension management algorithm for type 2 diabetic patients applied in primary care

Por Viana, Luciana V, Leitão, Cristiane B, Grillo, Maria F, Rocha, Ennio P C C, Brenner, Juliana K, Friedman, Rogerio, Gross, Jorge L
Publicado em 2013

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 dia...

Por Rojas, Arturo, Sposetti, Georgina, Gross, Jorge L., Barbieri, Douglas Eugenio, Duan, Ran, Linetzky, Bruno, De Lana, Janaina Martins, Stempa, Oded, Rodriguez, Angel
Publicado no Diabetol Metab Syndr (2016)

Are diabetes management guidelines applicable in ‘real life’?

Por Viana, Luciana V, Leitão, Cristiane B, Grillo, Maria de Fátima, Rocha, Ennio P C C, Brenner, Juliana K, Friedman, Rogério, Gross, Jorge L
Publicado em 2012

Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes

Por Rosenstock, Julio, Cefalu, William T., Hollander, Priscilla A., Belanger, Andre, Eliaschewitz, Freddy G., Gross, Jorge L., Klioze, Solomon S., St. Aubin, Lisa B., Foyt, Howard, Ogawa, Masayo, Duggan, William T.
Publicado em 2008

Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study

Por Viana, Luciana V, Leitão, Cristiane B, Kramer, Caroline K, Zucatti, Alessandra T N, Jezini, Deborah L, Felício, João, Valverde, Ana B, Chacra, Antonio R, Azevedo, Mirela J, Gross, Jorge L
Publicado em 2013